Professional
Added to YB: 2025-10-09
Pitch date: 2025-10-07
CTE.AX [bullish]
Cryosite Limited
+41.24%
current return
Author Info
Research as a Service is Australia’s leading independent investment research house sharing institutional-quality, issuer-sponsored research. Sign up for the newsletter.
Company Info
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments.
Market Cap
AUD 61.0M
Pitch Price
AUD 0.89
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.18
P/E
29.12
EV/Sales
4.27
Sector
Life Sciences Tools and Services
Category
value
Cryosite (ASX:CTE) - A Chilled Gem in Australia
CTE.AX: Australian clinical trials storage leader w/ 23% market share, 98% ROE, 78% ROCE. Ultra-frozen segment +58% revenue growth targeting CGT/mRNA therapies. Trades 11x EV/EBITDA vs peers at 21-74x. Acquisition target potential given regulatory moat (3+ yr barriers).
Read full article (8 min)